Autoinflammatory syndromes of STING and TREX1 dysfunction
Journal of Clinical Investigation · 01.06.2026 · 136 (11)
DOI: 10.1172/jci204549 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.06.2026. Verfasst von Debby J Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: RVCL Research Center, Department of Medicine. Hauptthemen laut MEDLINE: Exodeoxyribonucleases, Phosphoproteins, Membrane Proteins, Leukoencephalopathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Breakthroughs in rare genetic disease research elucidate the relationships among cytosolic DNA sensing, genome instability, and autoimmune disease phenotypes. Cytosolic self-DNA is a potent trigger of innate immunity, activating the DNA sensor cyclic GMP-AMP synthase (cGAS) and its downstream effector stimulator of interferon genes (STING). This pathway is negatively regulated by the DNA-degrading enzyme three-prime repair exonuclease 1 (TREX1); loss-of-function TREX1 variants lead to accumulation of cytosolic DNA, resulting in STING-mediated autoinflammation. Similarly, STING gain-of-function mutations cause STING-associated vasculopathy with onset in infancy, another disease characterized by multi-organ damage, disability, and premature death. The TREX1-cGAS-STING pathway has also been implicated in regulation of genome stability. Indeed, DNA damage lies at the heart of a separate TREX1-mediated disease, known as retinal vasculopathy with cerebral leukoencephalopathy, where the aberrant nuclear activity of mislocalized TREX1 damages genomic DNA, resulting in multi-organ degeneration syndrome with features of autoimmunity. Thus, monogenic autoimmune diseases and DNA damage syndromes sometimes overlap clinically, and the study of these diseases has created pathways for developing first-in-class small molecule therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- RVCL Research Center, Department of Medicine.
- Department of Microbiology.
- Institute for Immunology and Immune Health; and.
- Colton Center for Autoimmunity, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
Zitieren
APA
Park, D. J., Jones, K. M., Anderson, J. B., Finck, A. V., & Miner, J. J. (2026). Autoinflammatory syndromes of STING and TREX1 dysfunction. Journal of Clinical Investigation, 136(11). https://doi.org/10.1172/jci204549
Vancouver
Park DJ, Jones KM, Anderson JB, Finck AV, Miner JJ. Autoinflammatory syndromes of STING and TREX1 dysfunction. Journal of Clinical Investigation. 2026;136(11). doi:10.1172/jci204549
BibTeX
@article{Park2026,
author = {Park, Debby J and Jones, Kate M and Anderson, Jessica B and Finck, Amanda V and Miner, Jonathan J},
title = {Autoinflammatory syndromes of STING and TREX1 dysfunction},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {11},
doi = {10.1172/jci204549}
}
EUVIMED